|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current assets: | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Total current assets | |||||||
| Investments held in Trust Account | |||||||
| Total Assets | |||||||
| Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit: | |||||||
| Current liabilities: | |||||||
| Accounts payable | |||||||
| Accrued expenses | |||||||
| Accrued income tax | |||||||
| Franchise tax payable | |||||||
| Total current liabilities | |||||||
| Derivative warrant liabilities | |||||||
| Deferred underwriting commissions | |||||||
| Total Liabilities | |||||||
| Class A common stock, $0.0001 par value; 23,000,000 shares subject to possible redemption at $10.02 and $10.00 per share redemption value as of September 30, 2022 and December 31, 2021, respectively | |||||||
| Stockholders’ Deficit: | |||||||
| Class A common stock, $0.0001 par value; 380,000,000 shares authorized; no non-redeemable shares issued or outstanding | |||||||
| Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021 | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total stockholders’ deficit | |||||||
| Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit |
Loading...